Management of acute viral encephalitis in Brazil

Brazilian Journal of Infectious Diseases

Volumn 13, Issue 6, 2009, Pages 433-439

  Domingues, Renan Barros ^a,b   Teixeira, Antônio Lúcio ^b  

^a Escola Superior de Ciencias da Santa Casa de Misericordia de Vitoria   (Brazil)

^b FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

Acute viral encephalitis; Cerebrospinal fluid; Clinical management; Neuroimaging

Indexed keywords

ACICLOVIR; ANTICONVULSIVE AGENT; CORTICOSTEROID; FOSCARNET; GANCICLOVIR; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G ANTIBODY; METHYLPREDNISOLONE; PARACETAMOL; PLECONARIL; VALACICLOVIR; VALGANCICLOVIR; ANTIVIRUS AGENT;

ACUTE DISSEMINATED ENCEPHALOMYELITIS; ARBOVIRUS; ARTICLE; BLOOD LEVEL; BRAIN EDEMA; BRAZIL; CD4 LYMPHOCYTE COUNT; CEREBROSPINAL FLUID ANALYSIS; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CYTOMEGALOVIRUS INFECTION; DIAGNOSTIC APPROACH ROUTE; ENTEROVIRUS INFECTION; EPIDEMIC ENCEPHALITIS; HERPES SIMPLEX ENCEPHALITIS; HERPES ZOSTER ENCEPHALITIS; HUMAN; INTRACRANIAL HYPERTENSION; NEUROLOGIC EXAMINATION; NITROGEN BLOOD LEVEL; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PAIN; PLASMAPHERESIS; POLYMERASE CHAIN REACTION; PROGNOSIS; SEIZURE; SENSITIVITY AND SPECIFICITY; SIDE EFFECT; VIRUS ENCEPHALITIS; VIRUS LOAD; VIRUS REACTIVATION; ACUTE DISEASE; REVIEW; VIROLOGY;

ACUTE DISEASE; ANTIVIRAL AGENTS; BRAZIL; ENCEPHALITIS, VIRAL; HUMANS;

EID: 77953921847     PISSN: 14138670     EISSN: None     Source Type: Journal    
DOI: 10.1590/s1413-86702009000600009     Document Type: Article

References (79)

1. Stone M.J., Hawkins C.P. A medical overview of encephalitis. Neuropsychol Rehabil: 2007; 17: 429-449.
2. Solomon T., Hart I.J., Beeching N.J. Viral encephalitis: a clinician's guide. Pract Neurol 2007; 7: 288-305.
3. Sejvar J.J. The evolving epidemiology of viral encephalitis. Curr Opin Neurol 2006; 19:350-357.
4. Solomon T. Exotic and emerging encephalitides. Curr Opin Neurol 2003; 16:411-418.
5. Domingues R.B., Tsanaclis A.M.C., Pannuti C.S., Mayo M., Lakeman F.D. Evaluation of the range of clinical presentations of herpes simplex encephalitis by using polymerase chain reaction assay of cerebrospinal fluid samples. CID 1997; 25:86-91.
6. Lewis P., Glaser C.A. Encephalitis. Pediatr Rev 2005; 26:353-363.
7. Smith M.G., Lennete E.H., Reames H.R. Isolation of the virus of herpes simplex and demonstration of intranuclear inclusions in a case of acute encephalitis. Am J Pathol 1941; 17:55-68
8. Cassady K.A., Whitley R.J. Pathogenesis and pathophysiology of viral infections of the cntral nervous system. In: Scheld WM, Whitley RJ, Marra C, eds. Infections of the Central Nervous System, Lippincott Williams and Wilkins, 2004.
9. Kimberlin D.W. Management of HSV encephalitis in adults and neonates: diagnosis, prognosis and treatment. Herpes 2007; 14:11-16.
10. Nahmias A.J., Whitley R.J., Visintine A.N., Takei Y., Alford C.A. Herpes simplex encephalitis: laboratory evaluations and their diagnostic significance. JID 1982; 45:829-836.
11. Aurelius E., Johansson B., Sköldenberg B., Forsgren M. Encephalitis in immunocompetent patients due to herpes simplex virus type 1 or 2 as determined by type-specific polymerase chain reaction and antibody assays of cerebrospinal fluid. J Med Virol 1993; 39:179-186
12. Domingues R.B., Fink M.C.D., Tsanaclis A.M.C., de Castro C.C., Cerri C.C., Mayo M.S., Lakeman F.D. Diagnosis of herpes simplex encephalitis by magnetic resonance imaging and polymerase chain reaction assay of cerebrospinal fluid. J Neurol Sci 1998; 157:148-153.
13. Lakeman F.D., Whitley R.J. Diagnosis of herpes simplex encephalitis: application of polymerase chain reaction to cerebrospinal fluid from brain-biopsed patients and correlation with disease. JID 1995; 171:857-863.
14. Domingues R.B., Lakeman F.D., Pannuti C.S., Fink M.C.D., Tsanaclis A.M.C. Advantage of polymerase chain reaction in the diagnosis of herpes simplex encephalitis: presentation of five atypical cases. Scand J Infect Dis 1997; 29:229-231
15. Domingues R.B., Mayo M., Lakeman F.D., Whitley R.J. Application of competitive PCR to cerebrospinal fluid samples from patients with herpes simplex encephalitis. J Clin Microbiol 1998; 36:2229-2234.
16. Sköldenberg B., Alestig K., Burman L., Forkman A., Lövgren K., Norrby Y., Stiernstedt G., Forsgren M., Bergström T., Dahlqvist E., Frydén A., Norlin K., Olding-Stenkvist E., Uhnoo I., De Vahl K. Acyclovir versus vidarabine in herpes simplex encephalitis. Lancet 1984; 2:707-711.
17. Whitley R.J., Alford C.A., Hirsh M. S., Schooley R.T., Luby J.P., Aoki F.Y., Hanley D., Nahmias A.J., Soong S.J. Vidarabine versus acyclovir therapy in herpes simplex encephalitis. N Engl J Med 1986; 314:144-149.
18. Périgaud C., Gosselin G., Imbach J. Nucleoside analogues as chemotherapeutic agents: a review. Nucleosides and nucleotides 1992; 11:2-4.
19. Whitley R.J., Gnann J.W. Acyclovir: a decade later. N Engl J Med 1992; 327:782-789
20. O'Brien J.J., Campoli-Richards D.M. Acyclovir. An updated review of its antiviral activity, pharmacokinetic properties and therapeutic efficacy. Drugs 1989; 37:233-309.
21. Whitley R.J., Lakeman F.D. Herpes simplex virus infections of the central nervous system: therapeutic and diagnostic considerations. CID 1995; 20:414-420.
22. Saldanha J., Sutton R.N.P., Gannicliffe A., Farragher B., Fitzhaki R. Detection of HSV-1 DNA by in situ hybridization in human brain after immunossupression. J Neurol Neurosurg Psychiatry 1986; 49:613-619.
23. Gateley A., Genger R.M., Johnson P.C., Kit S., Ptsuka H., Kohl S. Herpes simplex virus type 2 meningoencephalitis resistant to acyclovir in a patient with AIDS. JID 1990; 161:711-715.
24. De Clercq E., Field H.J. Antiviral prodrugs - the development of successful prodrug strategies for antiviral chemotherapy. Br J Pharmacol 2006; 147:1-11.
25. MacDougall C., Guglielmo B.J. Pharmacokinetics of Valaciclovir. J Antimicrob Chemother 2004; 53:899-901.
26. Bale J.F. Jr. Human herpesviruses and neurological disorders of childhood. Semin Pediatr Neurol 1999; 6:278-287.
27. Steiner I., Kennedy P.G., Pachner A.R. The neurotropic herpes viruses: herpes simplex and varicella-zoster. Lancet Neurol 2007; 6:1015-1028.
28. Flamholc L. Neurological complications in herpes zoster. Scand J Infect Dis Suppl. 1996; 100:35-40.
29. Toledo P.V., Pellegrino L.N., Cunha C.A. Varicella-zoster virus encephalitis in an AIDS patient. Braz J Infect Dis 2004; 8:225-228.
30. McKelvie P.A., Collins S., Thyagarajan D., Trost N., Sheorey H., Byrne E. Meningoencephalomyelitis with vasculitis due to varicella zoster virus: a case report and review of the literature. Pathology 2002; 34:88-93.
31. Mathis S., Gil R., Neau J.P. Neurological complications of Herpes zoster. Rev Neurol [Paris. 2006; 162[8-9]:879-87.
32. Solomon T., Whitley R.J. Arthropod borne viral encphalitis. In: Scheld WM, Whitley RJ, Marra C, eds. Infections of the Central Nervous System, Lippincott Williams and Wilkins, 2004.
33. Coimbra T.L., Santos R.N., Petrella S., Nagasse-Sugahara T.K., Castrignano S.B., Santos C.L. Molecular characterization of two Rocio flavivirus strains isolated during the encephalitis epidemic in São Paulo State, Brazil and the development of a one-step RT-PCR assay for diagnosis. Rev Inst Med Trop Sao Paulo 2008; 50:89-94.
34. Medeiros D.B., Nunes M.R., Vasconcelos P.F., Chang G.J., Kuno G. Complete genome characterization of Rocio virus [Flavivirus: Flaviviridae], a Brazilian flavivirus isolated from a fatal case of encephalitis during an epidemic in Sao Paulo state. J Gen Virol 2007; 88:2237-2246.
35. Rocco I.M., Santos C.L., Bisordi I., Petrella S.M., Pereira L.E., Souza R.P., Coimbra T.L., Bessa T.A., Oshiro F.M., Lima L.B., Cerroni M.P., Marti A.T., Barbosa V.M., Katz G., Suzuki A. St. Louis encephalitis virus: first isolation from a human in São Paulo State, Brazil. Rev Inst Med Trop Sao Paulo 2005; 47:281-285.
36. Santos C.L., Sallum M.A., Franco H.M., Oshiro F.M., Rocco I.M. Genetic characterization of St. Louis encephalitis virus isolated from human in São Paulo, Brazil. Mem Inst Oswaldo Cruz. 2006; 101:57-63.
37. Ré V., Spinsanti L., Farías A., Díaz A., Vázquez A., Aguilar J., Tenorio A., Contigiani M. Reliable detection of St. Louis encephalitis virus by RT-nested PCR. Enferm Infecc Microbiol Clin 2008; 26:10-15.
38. Davis L.E., Beckham J.D., Tyler K.L. North American encephalitis arboviruses. Neurol Clin 2008; 26:727-757.
39. Davis L.E., DeBiasi R., Goade D.E., Haaland K.Y., Harrington J.A., Harnar J.B., Pergam S.A., King M.K., DeMasters B.K., Tyler KL. West Nile virus neuroinvasive disease. Ann Neurol 2006; 60:286-300.
40. Nogueira R.M., de Araújo J.M., Schatzmayr H.G. Dengue virus in Brazil, 1986-2006. Rev Panam Salud Publica 2007; 22:358-363.
41. Salomon T., Mallewa M. Dengue and other emerging Flaviviruses. J Infect 2001; 42:104-115.
42. Lum L.C.S., Lam S.K., Choy Y.S., George R., Harun F. Dengue encephalitis: a true entity? Am J Trop Med Hyg 1996; 54:256-259.
43. Hommel D., Talarmin A., Deubel V., Reynes J.M., Drouet M.T., Sarthou J.L., et al. Dengue encephalitis in French Guiana. Res Virol 1998; 149:235-238.
44. Salomon T., Dung N.M., Vaughn D.W., Kneen R., Thao L.T., Raengsakulrach B., et al. Neurological manifestations of dengue infection. Lancet 2000; 355:1053-1059.
45. George R., Lam S.K. Dengue virus infection-the Malaysian experience. Ann Acad Med Singapore 1997; 26:815-819.
46. Pancharoen C., Thisyakorn U. Neurological manifestations in Dengue patients. Southeast Asian J Trop Med Public Health 2001; 32:341-345.
47. Strobel M., Lamaury I., Contamin B., Jarrige B., Perez J.M., Steck A.J., et al. Fiévre dengue á expression neurologique. Ann Med Interne 1999; 150:79-82.
48. Vasconcelos P.F., da Rosa A.P., Coelho I.C., Menezes D.B., da Rosa E.S., Rodrigues SG, et al. Involvement of the central nervous system in dengue fever: three serologically confirmed cases from Fortaleza, Ceará, Brazil. Rev Inst Med Trop São Paulo 1998; 40:35-39.
49. Kankirawatana P., Choquephaibulkit K., Puthavathana P., Apintanapong S., Pongthapisit V. Dengue infections presenting with central nervous system manifestation. J Child Neurol 2000; 15:544-5447.
50. Domingues R.B., Kuster G.W., Onuki-Castro F., Souza V.A., Levi J.E., Pannuti C.S. Involvement of central nervous system in patients with dengue virus infections. J Neurol Sci 2008; 267:36-40.
51. Souza V.A.U.F., Tateno A.F., Oliveira R.R., Domingues R.B., et al. Sensitivity and specificity of three ELISA-based assays for discriminating primary fom secondary acute dengue infections. J Clin Virol 2007; 39:230-233
52. Domingues R.B., Kuster G.W., Onuki-Castro F., et al. Headache features in patients with dengue virus infections. Cephalalgia 2006; 26:879-882.
53. Steiner I., Budka H., Chaudhuri A., Koskiniemi M., Sainio K., Salonen O., Kennedy P.G. Viral encephalitis: a review of diagnostic methods and guidelines for management. Eur J Neurol 2005; 12:331-343.
54. Romero J.R., Kimberlin D.W. Molecular diagnosis of viral infections of the central nervous system. Clin Lab Med 2003; 23:843-865.
55. Tavakoli N.P., Wang H., Nattanmai S., Dupuis M., Fusco H., Hull R. Detection and typing of enteroviruses from CSF specimens from patients diagnosed with meningitis/encephalitis. J Clin Virol 2008; 43:207-211.
56. Dos Santos G.P., Skraba I., Oliveira D., Lima A.A., de Melo M.M., Kmetzsch C.I., da Costa E.V., da Silva E.E. Enterovirus meningitis in Brazil, 1998-2003. J Med Virol 2006; 78:98-104.
57. Hamaguchi T., Fujisawa H., Sakai K., Okino S., Kurosaki N., Nishimura Y., Shimizu H., Yamada M. Acute encephalitis caused by intrafamilial transmission of enterovirus 71 in adult. Emerg Infect Dis 2008; 14:828-830.
58. Pérez-Vélez C.M., Anderson M.S., Robinson C.C., McFarland E.J., Nix W.A., Pallansch M.A., Oberste M.S., Glodé M.P. Outbreak of neurologic enterovirus type 71 disease: a diagnostic challenge. Outbreak of neurologic enterovirus type 71 disease: a diagnostic challenge. Clin Infect Dis 2007; 45:950-957.
59. Lamarão L.M., Maciel A.M., Gomes M.L. First isolation of enterovirus 71 [EV-71] from Northern Brazil. Braz J Infect Dis 2003; 7:278-281.
60. Gomes M.L., de Castro C.M., Oliveira M.J., da Silva E.E. Neutralizing antibodies to enterovirus 71 in Belém, Brazil. Mem Inst Oswaldo Cruz 2002; 97:47-49.
61. Takimoto S., Waldman E.A., Moreira R.C., Kok F., Pinheiro F.P., Saes S.G., Hatch M., de Souza D.F., Carmona R.C., Shout D., de Moraes J.C., Costa A.M. Enterovirus 71 infection and acute neurological disease among children in Brazil [1988-1990]. Trans R Soc Trop Med Hyg 1998; 92:25-28.
62. Pevear D., Tull T., Seipel M., Groarke J. Activity of pleconaril against enteroviruses. Antimicrob Agents Chemother 1999; 43: 2109-2115.
63. Florea N., Maglio D., Nicolau D. Pleconaril, a novel antipicornaviral agent. Pharmacotherapy 2003; 23: 339-348.
64. Rotbart H.A., Webster A.D. Pleconaril Treatment Registry Group. Treatment of potentially threatening enterovirus infections with pleconaril. Clin Infect Dis 2001; 32:228-235.
65. Pevear D.C., Tull T.M., Seipel M.E., Groarke J.M. Activity of pleconaril against enteroviruses. Antimicrob Agents Chemother 1999; 43:2109-2115.
66. Griffiths P. Cytomegalovirus infection of the central nervous system. Herpes 2004; 11 Suppl 2:95A-104A.
67. Vancíková Z., Dvorák P. Cytomegalovirus infection in immunocompetent and immunocompromised individuals-a review. Curr Drug Targets Immune Endocr Metabol Disord 2001; 1:179-187.
68. Anduze-Faris B.M., Fillet A.M., Gozlan J., et al. Induction and maintenance therapy of cytomegalovirus central nervous system infection in HIV-infected patients AIDS 2000; 14:517-524.
69. Julin J.E., van Burik J.H., Krivit W., Webb C., Holman C.J., Clark H.B., Balfour H.H. Jr. Ganciclovir-resistant cytomegalovirus encephalitis in a bone marrow transplant recipient. Transpl Infect Dis 2002; 4:201-206.
70. Tenembaum S., Chitnis T., Ness J., Hahn J.S., International Pediatric MS Study Group. Acute disseminated encephalomyelitis. Neurology 2007; 68[16 Suppl 2]:S23-S36.
71. Tenembaum S., Chamoles N., Fejerman N. Acute disseminated encephalomyelitis: a long-term follow-up study of 84 pediatric patients. Neurology 2002; 59:1224-1231.
72. Klein C.J., Wijdicks E.F., Earnest F. 4th. Full recovery after acute hemorrhagic leukoencephalitis [Hurst's disease]. J Neurol 2000; 247:977-979.
73. Martins H.M., Teixeira A.L. Jr, Lana-Peixoto M.A., Brazilian Committee for Treatment and Research in Multiple Sclerosis. Acute hemorrhagic leukoencephalitis mimicking herpes simplex encephalitis: case report. Arq Neuropsiquiatr 2004; 62:139-143.
74. Whitley R.J., Cobbs C.G., Alford C.A., Soong S.J., Hirsch M.S., Connor J.D., Corey L., Hanley D.F., Levin M., Powell D.A. Diseases that mimic herpes simplex encephalitis: diagnosis, presentation, and outcome. JAMA 1989; 262:234-239.
75. Bergallo M., Costa C., Margio S., Sidoti F., Terlizzi M.E., Cavallo R. Development of a multiplex polymerase chain reaction for detection and typing of major human herpesviruses in cerebrospinal fluid. Can J Microbiol 2007; 53:1117-1122.
76. McIver C.J., Jacques C.F., Chow S.S., Munro S.C., Scott G.M., Roberts J.A., Craig M.E., Rawlinson W.D. Development of multiplex PCRs for detection of common viral pathogens and agents of congenital infections. J Clin Microbiol 2005; 43:5102-5110.
77. Boriskin Y.S., Rice P.S., Stabler R.A., Hinds J., Al-Ghusein H., Vass K., Butcher P.D. DNA microarrays for virus detection in cases of central nervous system infection. J Clin Microbiol 2004; 42:5811-5818.
78. Debiasi R.L., Tyler K.L. Molecular methods for diagnosis of viral encephalitis. Clin Microbiol Rev 2004; 17:903-925.
79. Calvario A, Bozzi A, Scarasciulli M, Ventola C, Seccia R, Stomati D, Brancasi B. Herpes Consensus PCR test: a useful diagnostic approach to the screening of viral diseases of the central nervous system. J Clin Virol 2002; 25 Suppl 1:S71-S78.